Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Kensuke Murata0
Date of Patent
July 23, 2019
0Patent Application Number
159174780
Date Filed
March 9, 2018
0Patent Primary Examiner
Patent abstract
Rivastigmine transdermal compositions are provided. Aspects of the transdermal compositions include an active agent layer which includes rivastigmine and a solubility modulator, e.g., crosslinked acrylic acid polymer. Also provided are methods of using the transdermal compositions and kits containing the transdermal compositions.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
